mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |